ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 177 filers reported holding ARGENX SE in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,503 | +27.2% | 119 | +0.8% | 0.00% | 0.0% |
| Q2 2023 | $45,987 | +5.5% | 118 | +0.9% | 0.00% | 0.0% |
| Q1 2023 | $43,590 | -4.1% | 117 | -2.5% | 0.00% | 0.0% |
| Q4 2022 | $45,459 | +5.7% | 120 | -3.2% | 0.00% | 0.0% |
| Q3 2022 | $43,000 | -6.5% | 124 | -1.6% | 0.00% | 0.0% |
| Q2 2022 | $46,000 | +48.4% | 126 | +38.5% | 0.00% | +100.0% |
| Q4 2021 | $31,000 | +29.2% | 91 | +8.3% | 0.00% | 0.0% |
| Q3 2021 | $24,000 | +4.3% | 84 | +5.0% | 0.00% | 0.0% |
| Q2 2021 | $23,000 | +9.5% | 80 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $21,000 | -12.5% | 80 | -2.4% | 0.00% | -50.0% |
| Q4 2020 | $24,000 | +20.0% | 82 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $20,000 | -16.7% | 82 | -26.1% | 0.00% | -50.0% |
| Q2 2020 | $24,000 | +166.7% | 111 | +35.4% | 0.00% | +100.0% |
| Q1 2020 | $9,000 | -30.8% | 82 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $13,000 | – | 82 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 49,950 | $14,690,000 | 5.25% |
| Avoro Capital Advisors LLC | 902,500 | $265,416,000 | 4.57% |
| Eagle Health Investments LP | 19,587 | $5,760,000 | 3.68% |
| Redmile Group, LLC | 918,307 | $270,065,000 | 3.27% |
| Bellevue Group AG | 945,348 | $278,018,000 | 3.18% |
| AWM Investment Company, Inc. | 80,000 | $23,527,000 | 2.99% |
| DCF Advisers, LLC | 24,000 | $7,058,000 | 2.91% |
| Ikarian Capital, LLC | 201,500 | $59,260,000 | 2.61% |
| JGP Global Gestao de Recursos Ltda. | 1,859 | $547,000 | 2.06% |
| Evolutionary Tree Capital Management, LLC | 8,798 | $2,587,000 | 1.97% |